Healthcare -
Medical - Care Facilities - NYSE - US
$ 7.92
-2.82 %
$ 400 M
Market Cap
-2.55
P/E
1. INTRINSIC VALUE
Balance Sheet
Enhabit, Inc.
| Current Assets | 193 M |
| Cash & Short-Term Investments | 28.4 M |
| Receivables | 149 M |
| Other Current Assets | 15.1 M |
| Non-Current Assets | 1.03 B |
| Long-Term Investments | 0 |
| PP&E | 70.5 M |
| Other Non-Current Assets | 963 M |
| Current Liabilities | 126 M |
| Accounts Payable | 6.7 M |
| Short-Term Debt | 35.1 M |
| Other Current Liabilities | 84.4 M |
| Non-Current Liabilities | 546 M |
| Long-Term Debt | 41.8 M |
| Other Non-Current Liabilities | 504 M |
EFFICIENCY
Earnings Waterfall
Enhabit, Inc.
| Revenue | 1.03 B |
| Cost Of Revenue | 531 M |
| Gross Profit | 504 M |
| Operating Expenses | 619 M |
| Operating Income | -115 M |
| Other Expenses | 38.9 M |
| Net Income | -154 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Enhabit, Inc.
| Net Income | -154 M |
| Depreciation & Amortization | 31.5 M |
| Capital Expenditures | -3.8 M |
| Stock-Based Compensation | 11.7 M |
| Change in Working Capital | 5.1 M |
| Others | 153 M |
| Free Cash Flow | 47.4 M |
Wall Street Analysts Price Targets
Enhabit, Inc.
Wall Street analysts predict an average 1-year price target for EHAB of $9.6 , with forecasts ranging from
a
low of
$8.5 to a high of $12 .
EHAB Lowest Price Target
Wall Street Target
8.5 USD
7.32%
EHAB Average Price Target
Wall Street Target
9.6 USD
21.21%
EHAB Highest Price Target
Wall Street Target
12 USD
51.52%
4. DIVIDEND
ANALYSIS
EHAB does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Enhabit, Inc.
Sold
0-3 MONTHS
9.4 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
244 K USD 2
3-6 MONTHS
98.7 K USD 1
6-9 MONTHS
184 K USD 2
9-12 MONTHS
7. News
Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
zacks.com
- 3 weeks ago
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock
Enhabit (EHAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zacks.com
- 1 month ago
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that it has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence by the Institute for Healthcare Improvement (IHI). This prestigious recognition honors Enhabit's dedication to providing high-quality, evidence-based care to older adults, ensuring their unique needs and preferences are consistently met. The Age-Friendly Health Systems initiative,.
businesswire.com
- 1 month ago
Enhabit, Inc. (EHAB) Q4 2024 Earnings Call Transcript
Enhabit, Inc. (NYSE:EHAB ) Q4 2024 Results Conference Call March 6, 2025 10:00 AM ET Company Participants Jobie Williams - Senior Vice President and Treasurer Barb Jacobsmeyer - President and Chief Executive Officer Ryan Solomon - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Ryan Langston - TD Cowen Operator Hello, and welcome to the Enhabit Inc. Fourth Quarter 2024 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Jobie Williams, Enhabit's Senior Vice President and Treasurer.
seekingalpha.com
- 1 month ago
Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.
zacks.com
- 1 month ago
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. “Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments,” said Barb Jacobsmeyer, president and chief executive officer of Enhabit. “In our home health segment, fourth quarter Medicare census continued to stabilize, and with th.
businesswire.com
- 1 month ago
Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum
Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
zacks.com
- 1 month ago
Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 6, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 I.
businesswire.com
- 2 months ago
Enhabit: Healthcare Predictive Analytics, FCF, Very Undervalued
EHAB's investments in healthcare predictive analytics, expected to grow at 23%-24% CAGR, could significantly boost future net income growth. Restructuring, activism, and strategic reviews are potential catalysts for stock price appreciation, enhancing financial flexibility from 2025 to 2030. Despite recent negative net income, EHAB's consistent positive cash flow and undervaluation indicate substantial upside potential in stock price.
seekingalpha.com
- 2 months ago
Enhabit Home Health & Hospice Earns 2025 Great Place To Work Certification™
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it's a great place to work, which is 26 points higher than the average U.S. company. Great Place To Work® is the global authority on workplace culture, employee experience and leadership behavi.
businesswire.com
- 2 months ago
Enhabit (EHAB) Shows Fast-paced Momentum But Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
zacks.com
- 2 months ago
Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners
BIRMINGHAM, Ala., and DALLAS , Dec. 4, 2024 /PRNewswire/ -- On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit.
prnewswire.com
- 4 months ago
8. Profile
Summary
Enhabit, Inc. EHAB
COUNTRY
US
INDUSTRY
Medical - Care Facilities
MARKET CAP
$ 400 M
Dividend Yield
0.00%
Description
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Contact
6688 N. Central Expressway, Dallas, TX, 75206
https://www.ehab.com
IPO
Date
June 23, 2022
Employees
10700
Officers
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
President, Chief Executive Officer & Director
Ms. Julie Diane Jolley B.S.N., R.N.
Executive Vice President of Home Health
Mr. Ryan Solomon
Chief Financial Officer
Ms. Jeanne Kalvaitis B.S.N., R.N.
Executive Vice President of Hospice Operations
Mr. Ronald L. Langham Jr., M.B.A., P.T.
Executive Vice President of Clinical Excellence & Strategy
Mr. Dylan C. Black
General Counsel & Secretary
Ms. Tanya R. Marion
Chief Human Resources Officer